GlassScriptPhysician profile
Gregory T Marecki
NPI 1881129856
$8,749.43
in general payments reported to CMS, 2019-2025
14 companies · $5,873 in 2025
The $5,873 reported for 2025 was more than what 99% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $250 · 2022: $149 · 2023: $155 · 2024: $2,322 · 2025: $5,873.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,764 · Food and Beverage: $3,587.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,763.82 |
| Food and Beverage | $3,587.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,112.82 | 2023-2025 | Thoratec Heartmate 3 Lvas Implant Kit, 2nd Gen Centrimag Primary Console, Cardiomems |
| Abiomed | $944.44 | 2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $551.34 | 2022-2025 | Wainua, Farxiga |
| Cvrx, INC. | $308.05 | 2025 | Barostim Neo System |
| Janssen Pharmaceuticals, INC | $272.39 | 2021-2022 | |
| Medtronic, INC. | $168.84 | 2024 | Cobalt Dr Mri Surescan |
| Merck Sharp & Dohme LLC | $108.23 | 2024-2025 | Verquvo, Winrevair |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.58 | 2024-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.16 | 2024-2025 | Jardiance |
| Pfizer INC. | $51.26 | 2023-2024 | |
| Amgen INC. | $29.20 | 2024 | |
| Heartflow, INC. | $24.28 | 2024 | |
| Lilly USA, LLC | $21.48 | 2024 | |
| Novartis Pharmaceuticals Corporation | $15.36 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Marecki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.